|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ji K, Wang B, Shao YT, Zhang L, Liu YN,
Shao C, Li XJ, Li X, Hu JD, Zhao XJ, et al: Synergistic suppression
of prostatic cancer cells by coexpression of both murine double
minute 2 small interfering RNA and wild-type p53 gene in vitro and
in vivo. J Pharmacol Exp Ther. 338:173–183. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chappell WH, Lehmann BD, Terrian DM,
Abrams SL, Steelman LS and McCubrey JA: p53 expression controls
prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor
Nutlin-3. Cell Cycle. 11:4579–4588. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shiota M, Yokomizo A, Tada Y, Inokuchi J,
Tatsugami K, Kuroiwa K, Uchiumi T, Fujimoto N, Seki N and Naito S:
Peroxisome proliferator-activated receptor gamma coactivator-1alpha
interacts with the androgen receptor (AR) and promotes prostate
cancer cell growth by activating the AR. Mol Endocrinol.
24:114–127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ogasawara MA, Liu J, Pelicano H, Hammoudi
N, Croce CM, Keating MJ and Huang P: Alterations of mitochondrial
biogenesis in chronic lymphocytic leukemia cells with loss of p53.
Mitochondrion. 31:33–39. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Basu S, Gnanapradeepan K, Barnoud T, Kung
CP, Tavecchio M, Scott J, Watters A, Chen Q, Kossenkov AV and
Murphy ME: Mutant p53 controls tumor metabolism and metastasis by
regulating PGC-1α. Genes Dev. 32:230–243. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Villena JA: New insights into PGC-1
coactivators: Redefining their role in the regulation of
mitochondrial function and beyond. FEBS J. 282:647–672. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Piantadosi CA and Suliman HB:
Transcriptional regulation of SDHa flavoprotein by nuclear
respiratory factor-1 prevents pseudo-hypoxia in aerobic cardiac
cells. J Biol Chem. 283:10967–10977. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li PA, Hou X and Hao S: Mitochondrial
biogenesis in neurodegeneration. J Neurosci Res. 95:2025–2029.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Martin OJ, Lai L, Soundarapandian MM,
Leone TC, Zorzano A, Keller MP, Attie AD, Muoio DM and Kelly DP: A
role for peroxisome proliferator-activated receptor γ coactivator-1
in the control of mitochondrial dynamics during postnatal cardiac
growth. Circ Res. 114:626–636. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cartoni R, Léger B, Hock MB, Praz M,
Crettenand A, Pich S, Ziltener JL, Luthi F, Dériaz O, Zorzano A, et
al: Mitofusins 1/2 and ERRalpha expression are increased in human
skeletal muscle after physical exercise. J Physiol. 567:349–358.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo K, Lu J, Huang Y, Wu M, Zhang L, Yu H,
Zhang M, Bao Y, He JC, Chen H and Jia W: Protective role of PGC-1α
in diabetic nephropathy is associated with the inhibition of ROS
through mitochondrial dynamic remodeling. PLoS One.
10:e01251762015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dabrowska A, Venero JL, Iwasawa R, Hankir
MK, Rahman S, Boobis A and Hajji N: PGC-1α controls mitochondrial
biogenesis and dynamics in lead-induced neurotoxicity. Aging
(Albany NY). 7:629–647. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peng K, Yang L, Wang J, Ye F, Dan G, Zhao
Y, Cai Y, Cui Z, Ao L, Liu J, et al: The interaction of
mitochondrial biogenesis and fission/fusion mediated by PGC-1α
regulates rotenone-induced dopaminergic neurotoxicity. Mol
Neurobiol. 54:3783–3797. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shen L, Sun B, Sheng J, Yu S, Li Y, Xu H,
Su J and Sun L: PGC1α promotes cisplatin resistance in human
ovarian carcinoma cells through upregulation of mitochondrial
biogenesis. Int J Oncol. 53:404–416. 2018.PubMed/NCBI
|
|
17
|
Xu L, Xie Q, Qi L, Wang C, Xu N, Liu W, Yu
Y, Li S and Xu Y: Bcl-2 overexpression reduces cisplatin
cytotoxicity by decreasing ER-mitochondrial Ca2+ signaling in SKOV3
cells. Oncol Rep. 39:985–992. 2018.PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu Y, Gao WN, Xue YN, Zhang LC, Zhang JJ,
Lu SY, Yan XY, Yu HM, Su J and Sun LK: SIRT3 aggravates
metformin-induced energy stress and apoptosis in ovarian cancer
cells. Exp Cell Res. 367:137–149. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen X, Zhong J, Dong D, Liu G and Yang P:
Endoplasmic reticulum stress-induced CHOP inhibits PGC-1α and
causes mitochondrial dysfunction in diabetic embryopathy. Toxicol
Sci. 158:275–285. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koczor CA, White RC, Zhao P, Zhu L, Fields
E and Lewis W: p53 and mitochondrial DNA: Their role in
mitochondrial homeostasis and toxicity of antiretrovirals. Am J
Pathol. 180:2276–2283. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Aquilano K, Baldelli S, Pagliei B, Cannata
SM, Rotilio G and Ciriolo MR: p53 orchestrates the PGC-1α-mediated
antioxidant response upon mild redox and metabolic imbalance.
Antioxid Redox Signal. 18:386–399. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sahin E, Colla S, Liesa M, Moslehi J,
Müller FL, Guo M, Cooper M, Kotton D, Fabian AJ, Walkey C, et al:
Telomere dysfunction induces metabolic and mitochondrial
compromise. Nature. 470:359–365. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang LN, Zhou HY, Fu YY, Li YY, Wu F, Gu
M, Wu LY, Xia CM, Dong TC, Li JY, et al: Novel small-molecule
PGC-1α transcriptional regulator with beneficial effects on
diabetic db/db mice. Diabetes. 62:1297–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li W, Li X, Wang B, Chen Y, Xiao A, Zeng
D, Ou D, Yan S, Li W and Zheng Q: ZLN005 protects cardiomyocytes
against high glucose-induced cytotoxicity by promoting SIRT1
expression and autophagy. Exp Cell Res. 345:25–36. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu Y, Kabba JA, Ruan W, Wang Y, Zhao S,
Song X, Zhang L, Li J and Pang T: The PGC-1α activator ZLN005
ameliorates ischemia-induced neuronal injury in vitro and in vivo.
Cell Mol Neurobiol. 38:929–939. 2018. View Article : Google Scholar : PubMed/NCBI
|
